Medical technology company iSonea Ltd has launched its first asthma
management smartphone app, AsthmaSense, which is now available to iPhone, iPad,
and Android users worldwide.
AsthmaSense is a smartphone app designed to help people improve the way
they live with and manage asthma. The product launch is expected to trigger
immediate revenues from app downloads. The app will be available for purchase
worldwide from the Apple App Store for iPhone and iPad users and Google Play
and Amazon App Stores for android users. The app will
cost consumers $3.99 (additional local costs may apply) and will be a one-time
purchase.
Users will be able to input their personalized, physician recommended
asthma action plan into the app. From that point forward, AsthmaSense ensures
users are tracking their own plan with active reminders. It enables symptoms,
medication usage, and lung function testing data to be recorded and displays
the user’s trends in an easy-to-read graphical format.
Unlike other asthma apps that deliver limited functionality, iSonea’s
AsthmaSense is a comprehensive, personalized tool that brings together
everything a person with asthma needs to better manage their condition,
including alerts when symptoms suggest that risk of an attack has increased.
AsthmaSense lays the foundation for a family of future asthma
management smart apps to be released by the company in the coming months,
including one that will combine iSonea’s proprietary Acoustic Respiratory
Monitoring (ARM) sensory technology and diagnostic algorithms into mobile
health platforms.
Source: iSonea Limited
